Carcinotech Ltd logo

Carcinotech Ltd

Enabling Cancer Treatment Breakthroughs

23 employees · est. 2018 · Edinburgh, United Kingdom

VS
Repositive - no longer trading logo

Repositive - no longer trading

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners

1 employees · est. 2014 · Cambridge, United Kingdom

Repositive - no longer trading is the older company (2018 vs 2014); Carcinotech Ltd is the larger of the two.

Side-by-Side Comparison

Carcinotech Ltd Repositive - no longer trading
Founded
2018 2014 older
Headquarters
Edinburgh, United Kingdom Cambridge, United Kingdom
Employees
23 larger 1
Industry
Biotechnology, Life Sciences Analytics, Big Data, Data Analytics
Funding Stage
Seed Series A
Total Funding
$5.80M $3.30M
Funding Rounds
2 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cancer Research, Precision Oncology, 3D Bioprinting, Drug Discovery, Personalised Medicine Testing, MedTech, Tissue Engineering, Robotic Manufacturing, Cancer Microenvironment, Pharma Industry Collaboration Biomedical Research, Precision Cancer Therapies, Preclinical Cancer Models, Contract Research Organisations, Oncology Projects, AI In Drug Discovery, Genomic Data Sharing, Biotech, Pharma, Translational Oncology
Website
carcinotech.com repositive.io
Carcinotech Ltd logo

About Carcinotech Ltd

Carcinotech Ltd is a MedTech company founded in 2018 and headquartered in the United Kingdom. The company's slogan, "Reinventing Cancer Research," reflects its mission to revolutionize cancer treatment through innovative technology. Carcinotech specializes in manufacturing 3D printed micro-tumours...

Repositive - no longer trading logo

About Repositive - no longer trading

Repositive is a United Kingdom-based startup committed to expediting the development of precision cancer therapies by collaborating with biopharmas and Contract Research Organisations (CROs). Founded in 2014, the company's slogan "Accelerating biomedical research by connecting biopharmas with the ri...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Carcinotech Ltd and Repositive - no longer trading — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Carcinotech Ltd and Repositive - no longer... — by email.

Frequently Asked Questions

Carcinotech Ltd — Enabling Cancer Treatment Breakthroughs. Repositive - no longer trading — Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Carcinotech Ltd has raised $5.80M while Repositive - no longer trading has raised $3.30M.
Carcinotech Ltd and Repositive - no longer trading operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Carcinotech Ltd with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy